Literature DB >> 1150888

Reduced lymphocyte transformation in early cancer of the breast.

L A Knight, W M Davidson.   

Abstract

The cell mediated immune response has been measured in vitro by lymphocyte transformation in 53 patients with malignant tumours of the breast and an equal number of patients in the same age group operated upon for benign tumours. The response to phytohaemagglutinin (PHA) was reduced in the patients with malignant tumours when the lymphocytes were grown either in the patient's plasma or in autologous plasma. This was observed when the response was measured both by the uptake of radioactive DNA precursor and by autoradiography. Reduced lymphocyte transformation was present even very early in the disease and certainly preoperatively. The reduction appeared to be even more marked in the advanced cases. An interesting finding was that the plasma from cancer patients contained a factor which reduced the PHA transformation of lymphocytes from a healthy donor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150888      PMCID: PMC475714          DOI: 10.1136/jcp.28.5.372

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Unresponsiveness of human B lymphocytes to phytohaemagglutinin.

Authors:  R S Geha; F S Rosen; E Merler
Journal:  Nature       Date:  1974-03-29       Impact factor: 49.962

2.  Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.

Authors:  R N MacSween; M A Thomas
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  Reduced lymphocyte transformation in breast cancer.

Authors:  M G Whittaker; K Rees; C G Clark
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

4.  Serum inhibitors of lymphocyte responses.

Authors:  R A Gatti
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

5.  Activation of T and B lymphocytes by insoluble phytomitogens.

Authors:  M F Greaves; S Bauminger
Journal:  Nat New Biol       Date:  1972-01-19

6.  The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients.

Authors:  S Kumar; G Taylor
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

7.  Impaired lymphocyte transformation and chromosomal abnormalities in fatal granulomatosus disease of childhood.

Authors:  R D Barnes; N P Bishun; J Holliday
Journal:  Acta Paediatr Scand       Date:  1970-07

8.  Effect of serum from cancer patients on homologous lymphocyte cultures.

Authors:  E K Golob; T Israsena; A C Quatrale; K L Becker
Journal:  Cancer       Date:  1969-02       Impact factor: 6.860

Review 9.  Cell-mediated immunity.

Authors:  F T Valentine; H S Lawrence
Journal:  Adv Intern Med       Date:  1971

10.  Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

Authors:  P G Scheurlen; W Schneider; A Pappas
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

View more
  2 in total

1.  Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer.

Authors:  A Burford-Mason; G M Gyte; S M Watkins
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

2.  Lymphocyte transformation in cancer patients: variation in results according to technique.

Authors:  G M Gyte; S M Watkins
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.